Where does HM.CLAUSE, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), HM.CLAUSE, Inc. ranks #3,627 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does HM.CLAUSE, Inc. hold?

HM.CLAUSE, Inc. holds 101 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is HM.CLAUSE, Inc.'s Innovation Score?

HM.CLAUSE, Inc. has an Innovation Score of 45.4 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does HM.CLAUSE, Inc. focus on?

HM.CLAUSE, Inc.'s top technology area is A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques) with 101 patents, ranking #12 of 285 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is HM.CLAUSE, Inc.'s patent grant rate increasing or decreasing?

HM.CLAUSE, Inc.'s recent grant velocity is +29% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for HM.CLAUSE, Inc.'s patents?

HM.CLAUSE, Inc.'s patents average 24.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the HM.CLAUSE, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

HM.CLAUSE, Inc.

USPTO PatentsView assignee record - 101 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hm.clause ranks #3,627 of 49,997 tracked US assignees by granted-patent volume, with 101 patents across 4 technology areas.

#3,627
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.4/100): 24.4
avg claims per patent: +29%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3627 · US Corporation #3,627 · 101 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 101 grants
TOP-DECILE #3,627/49,997
PHOTO-FINISH CuRNA
CPC-NARROW A01H · 4 areas
INNOV-PAR 45.4/100
CLAIMS-DENSE 24.4 claims/avg
TYPE-USCORP US Corporation
VEL-UP +29% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: CuRNA, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Hm.clause’s 45.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.0 pts (35%) Velocity 7.7 pts (17%) Breadth 7.1 pts (16%) Claim depth 14.7 pts (32%)

Qualcomm Incorporated · highest

85
Ceres · near

45
PureCircle Sdn Bhd · near

45
Capstan Systems · near

45
HM CLAUSE · this assignee

45
Kreg Enterprises · near

45
3D Lighting… · lowest

7

What this shows Hm.clause's Innovation Score is 45.4/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Hm.clause?

Each dot is one of Hm.clause’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Hm.clause’s own 24.4 claims/patent is ABOVE the 11.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Hm.clause vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Hm.clause's grants concentrate

HM.CLAUSE, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques). Peak complete grant year is 2019 (16 grants) versus a trough of 1 in 2015. By volume, Hm.clause sits between CuRNA, Inc. and Nanolumens Acquisition, Inc..

Hm.clause's three-year grant acceleration

From 2019–2021 to 2022–2024, HM.CLAUSE, Inc. moved from 32 to 37 grants (1.16x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #857. See the growth leaderboard.

Curna

101
Delphi Internatio…

101
FCI Americas Tech…

101
Fameccanica Data…

101
James Hardie Tech…

101
Lucas Automotive

101
Lacrosse Footwear

101
Nanolumens Acquis…

101
HM Clause ◀

101

What this shows HM.CLAUSE holds 101 patents at rank #3,627, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near HMCLAUSE

By rank, the assignees closest to #3,627 in granted patent volume.

Leaders in A01H (NEW Plants OR)

Other assignees with the most granted patents in HMCLAUSE's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for HMCLAUSE, neither rank-band nor same-CPC leaders (those blocks stay above). In A01H (NEW Plants OR), HMCLAUSE ranks #12 of 285 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Capstan Ag Systems, Inc. 45 Kreg Enterprises, Inc. 45 PureCircle Sdn Bhd 45 Ceres, Inc. 45

Similar claim depth

Nearest assignees by average claims per patent (24.4 here).

NextNav, LLC 24.4 avg Ventana Micro Systems Inc. 24.5 avg Zoll Medical Corporation 24.4 avg Headwater Partners II LLC 24.4 avg

Hm.clause's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

HM.CLAUSE, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	1.0%
2016	5	5.0%
2017	6	5.9%
2018	13	12.9%
2019	16	15.8%
2020	8	7.9%
2021	8	7.9%
2022	14	13.9%
2023	10	9.9%
2024	13	12.9%
2025partial year	7	6.9%

Which technologies does HM.CLAUSE, Inc. patent most?

A01H - NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques 101

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 14

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

C07K - Peptides 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

HM.CLAUSE, Inc.'s patent record in context - here's where to go next.

HM.CLAUSE, Inc.'s lead technology class is A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques), 100% of its portfolio - see every assignee active in that class. Explore A01H
Ranked #3,627 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare HM.CLAUSE, Inc. against CuRNA, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.